Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Conroy

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
BMC Bioinformatics|April 19, 2015
SCNVSim: somatic copy number variation and structure variation simulatorMaochun Qin, Biao Liu, Jeffrey M Conroy, et al.
Cancers|October 14, 2023
PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment OutcomesMary K Nesline, Rebecca A Previs, Grace K Dy, et al.
American Journal of Cancer Research|May 10, 2024
Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targetingPeter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
NPJ Genomic Medicine|August 8, 2023
T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapyHirotaka Miyashita, Razelle Kurzrock, Nicholas J Bevins, et al.
Mutation Research|January 2, 2007
aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABLJeremy D Bartos, Daniel P Gaile, Devin E McQuaid, et al.
Immunotargets and Therapy|September 12, 2025
B7-H3/CD276: Novel Immune Checkpoint and Jack of All TradesBrigid Larkin, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Oncotarget|September 10, 2019
Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assaySarabjot Pabla, Jonathan Andreas, Felicia L Lenzo, et al.
American Journal of Cancer Research|June 11, 2024
The transcriptomic expression pattern of immune checkpoints shows heterogeneity between and within cancer typesHirotaka Miyashita, Nicholas J Bevins, Kartheeswaran Thangathurai, et al.
Oncoimmunology|December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumabSaby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
BMC Bioinformatics|April 19, 2015
SCNVSim: somatic copy number variation and structure variation simulatorMaochun Qin, Biao Liu, Jeffrey M Conroy, et al.
Cancers|October 14, 2023
PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment OutcomesMary K Nesline, Rebecca A Previs, Grace K Dy, et al.
American Journal of Cancer Research|May 10, 2024
Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targetingPeter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
NPJ Genomic Medicine|August 8, 2023
T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapyHirotaka Miyashita, Razelle Kurzrock, Nicholas J Bevins, et al.
Mutation Research|January 2, 2007
aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABLJeremy D Bartos, Daniel P Gaile, Devin E McQuaid, et al.
Immunotargets and Therapy|September 12, 2025
B7-H3/CD276: Novel Immune Checkpoint and Jack of All TradesBrigid Larkin, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Oncotarget|September 10, 2019
Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assaySarabjot Pabla, Jonathan Andreas, Felicia L Lenzo, et al.
American Journal of Cancer Research|June 11, 2024
The transcriptomic expression pattern of immune checkpoints shows heterogeneity between and within cancer typesHirotaka Miyashita, Nicholas J Bevins, Kartheeswaran Thangathurai, et al.
Oncoimmunology|December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumabSaby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Pageof 7